TMTP1 Targeting Micro-metastasis LN in Laparoscopic SLN Detection in Cervical Cancer
Novel Tumor Targeted Fluorescent Peptide TMTP1-ICG Mapping in Laparoscopic Sentinel Micro-metastasis Lymph Node Detection in Cervical Cancer Patients
Sponsor: Huazhong University of Science and Technology
This NA trial investigates Cervical Cancer and Sentinel Lymph Node and is currently ongoing. Huazhong University of Science and Technology leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jul 2018 — Jun 2020 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Huazhong University of Science and Technology
For direct contact, visit the study record on ClinicalTrials.gov .